Figure 1: Maximum intensity projections of Subject-1. More lesions can be seen on the baseline RGD-K5 scan compared to the FDG scan. The uptake decreases after the patient receives 8 weeks of paclitaxel and carboplatin (given weekly) with 4 doses of bevacizumab (given bi-weekly). The pre-treatment FDG uptake is much lower than the RGD-K5 uptake. No new lesions were discovered during the course of treatment.